| Cell line name |
NZM103 |
|---|
| Accession |
CVCL_0D62 |
|---|
| Resource Identification Initiative |
To cite this cell line use: NZM103 (RRID:CVCL_0D62) |
|---|
| Sequence variations |
- Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=32567790).
- Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790).
|
|---|
| Disease |
Melanoma (NCIt: C3224) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Category |
Cancer cell line |
|---|
| STR profile |
Source(s): PubMed=32567790
Markers:| Amelogenin | X |
| CSF1PO | 10,11 |
| D2S1338 | 17,20 |
| D3S1358 | 16,17 |
| D5S818 | 11,12 |
| D7S820 | 7,9 |
| D8S1179 | 13 |
| D13S317 | 9 |
| D16S539 | 9,10 |
| D18S51 | 13,18 |
| D19S433 | 14 |
| D21S11 | 30,32.2 |
| FGA | 22 |
| TH01 | 9,9.3 |
| TPOX | 8,9 |
| vWA | 14,18 |
Run an STR similarity search on this cell line |
|---|
| Publications | PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249
Tran K.B., Gimenez G., Tsai P., Kolekar S., Rodger E.J., Chatterjee A., Jabed A., Shih J.-H., Joseph W.R., Marshall E.S., Wang Q., Print C.G., Eccles M.R., Baguley B.C., Shepherd P.R.
Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: a valuable model for studying the impact of genetic diversity in melanoma.
Pigment Cell Melanoma Res. 34:136-143(2021) |
|---|
| Cross-references |
|---|
| Cell line databases/resources |
cancercelllines; CVCL_0D62
|
|---|
| Encyclopedic resources |
Wikidata; Q54931523
|
|---|
| Entry history |
|---|
| Entry creation | 10-Apr-2015 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 8 |
|---|
